Finance

Lists
PPLPHARMA:NSE
Piramal Pharma Ltd (Mumbai)
₹ २३८.००
-१.१२%
(-२.७०) 1D
नोभेम्बर १८, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PPLPHARMA...
Open
₹ २४०.७०
High
₹ २४३.७६
Low
₹ २३७.३२
Mkt. cap
३.१४ खरब
Avg. vol.
८७.७१ लाख
Volume
२८.३५ लाख
52-wk high
₹ २५३.९०
52-wk low
₹ १३२.३०
EPS
-₹ १.५८
No. of employees
७ हजार
Open
₹ २४०.७०
High
₹ २४३.७६
Low
₹ २३७.३२
Mkt. cap
३.१४ खरब
Avg. vol.
८७.७१ लाख
Volume
२८.३५ लाख
52-wk high
₹ २५३.९०
52-wk low
₹ १३२.३०
EPS
-₹ १.५८
No. of employees
७ हजार
News stories
From web sources and news partners
San Luis Obispo Tribune
San Luis Obispo Tribune
·
२० मिनेट पहिले
S&P 500, Nasdaq open higher as Nvidia forecast eases AI jitters
Yahoo Finance
Yahoo Finance
·
५६ मिनेट पहिले
Investors Love the S&P 500 Index. Here’s Why I Don’t.
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Movers on Nov. 18
About Piramal Pharma Ltd (Mumbai)
CEOPeter DeYoung
Employees७.१२ हजार
Founded२०२०
Headquarters-
SectorHealth Care
Industry-
Last report
२०२६ अक्टोबर २८
Fiscal period
Q2 2027
₹ ०.०४ / -₹ ०.३८
+११०.५७%beat
Revenue / Est. (INR)
२६.१७ अरब / २३.५८ अरब
+११.००%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२१.४० अरब
२७.५२ अरब
२२.७० अरब
२६.१७ अरब
Cost of goods sold
७.८६ अरब
१३.९५ अरब
८.५२ अरब
९.०६ अरब
Cost of revenue
७.८६ अरब
१३.९५ अरब
८.५२ अरब
९.०६ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.०० अरब
८.१९ अरब
६.७६ अरब
७.१४ अरब
Operating expense
१३.७१ अरब
११.०९ अरब
१४.४६ अरब
१५.९५ अरब
Total operating expenses
२१.५७ अरब
२५.०४ अरब
२२.९८ अरब
२५.०१ अरब
Operating income
-१७.०१ करोड
२.४७ अरब
-२८.३५ करोड
१.१६ अरब
Other non operating income
४३.२४ करोड
-९७.७९ करोड
८९.४१ करोड
३५.९३ करोड
EBT including unusual items
-९३.८६ करोड
४३.०० करोड
-७.४६ करोड
८१.६३ करोड
EBT excluding unusual items
-५२.७५ करोड
१.४० अरब
-७.४६ करोड
८१.६३ करोड
Income tax expense
४२.३३ करोड
५१.८३ करोड
६१.९३ करोड
७६.६० करोड
Effective tax rate
-४५.१०%
१२०.५३%
-८३०.१६%
९३.८४%
Other operating expenses
५.५८ अरब
७२.३३ करोड
५.४७ अरब
६.४८ अरब
Net income
-१.३६ अरब
-८.८३ करोड
-६९.३९ करोड
५.५८ करोड
Net profit margin
-६.३६%
-०.३२%
-३.०६%
०.२१%
Earnings per share
-०.७२
१.३२
-०.५२
०.०४
Interest and investment income
-
७.०७ करोड
-
-
Interest expense
-८९.२४ करोड
-८०.५४ करोड
-८८.०८ करोड
-८७.६३ करोड
Net interest expenses
-८९.२४ करोड
-७३.४७ करोड
-८८.०८ करोड
-८७.६३ करोड
Depreciation and amortization charges
२.१३ अरब
२.१८ अरब
२.२४ अरब
२.३३ अरब
EBITDA
१.६८ अरब
४.३२ अरब
१.५७ अरब
३.२९ अरब
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू